Observational studyEuropean heart journal. Cardiovascular pharmacotherapy2025

Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug.

Stefano Fumagalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.